Atlas Trials

Omega-3 Fatty Acids Monotherapy in Children and Adolescents With Autism Spectrum Disorders

Clinical trial NCT01248130 · TERMINATED

Trial details

NCT number
NCT01248130
Sponsor
Massachusetts General Hospital
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Autism Spectrum Disorder (ASD)
Start date
2009-11-01
Primary completion
2013-04-01
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.